Glaxosmithkline | GSK - Créanciers Commerciaux

Prix De L'Action
51.83
Variation Quotidienne
-7.29 -12.33%
Mensuellement
-12.54%
Annuel
32.66%
Q2 Prévisions
53.52




Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bausch Health Companies USD 593M 7M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Canopy Growth CAD 19.96M 1.83M 2025-12
Corcept Therapeutics USD 33.31M 7.14M 2026-03
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.03B 350M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Glaxosmithkline GBP 20.72B 346.14M 2025-12
J&J USD 10.46B 1.53B 2026-03
Merck USD 4.4B 257M 2025-12
Novartis USD 4.46B 99M 2025-12
Pacira USD 14.01M 1.14M 2026-03
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Zoetis USD 487M 77M 2025-12